Jun 28, 2021

Proceedings from the first in a series of 11 summer webinars held following the 2021 ONS Annual Congress. Featuring perspectives from Ms Allie Hershey and Dr Sara M Tolaney, including the following topics:

• Introduction (0:00)
• Management of Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer (11:54)
• Case: A woman in her early 40s with ER/PR (progesterone receptor)-positive, HER2-negative, node-positive breast cancer — Sara M Tolaney, MD, MPH (12:39)
• Case: A woman in her early 60s with hormone receptor-positive, node-positive breast cancer —Allie Hershey, MSN, RN, ANP-BC, AOCNP (19:23)
• Treatment of HER2-Positive Breast Cancer (30:44)
• Case: A woman in her mid-40s with hormone receptor-positive, HER2-positive metastatic breast cancer — Ms Hershey (32:29)
• Case: A woman in her mid-30s with ER-positive, HER2-positive metastatic breast cancer — Dr Tolaney (42:16)
• Clinical Considerations for Patients with Triple-Negative Breast Cancer (TNBC) (48:06) 
• Case: A woman in her early 50s with metastatic TNBC — Ms Hershey (49:27)

CME information and select publications